Literature DB >> 29774406

Reduced global myocardial perfusion reserve in DCM and HCM patients assessed by CMR-based velocity-encoded coronary sinus flow measurements and first-pass perfusion imaging.

Michael Bietenbeck1, Anca Florian1, Zornitsa Shomanova1, Claudia Meier1, Ali Yilmaz2.   

Abstract

BACKGROUND: Coronary microvascular dysfunction (CMD) is an independent predictor of poor prognosis in patients suffering from dilative or hypertrophic cardiomyopathy (DCM/HCM). To assess CMD, quantitative myocardial first-pass perfusion (1P) cardiovascular magnetic resonance (CMR) can be performed. Coronary sinus flow (CSF) measurements at rest and during maximal vasodilatation are an alternative and well-validated approach for the quantification of global myocardial blood flow (MBF) in CMR.
METHODS: Global myocardial perfusion reserve (MPR) was used to compare both methods, 1P and CSF. This measure reflects the ratio of myocardial blood flow during maximal coronary vasodilatation over rest. 1P-MPR and CSF-MPR were calculated in 17 HCM patients, 14 DCM patients and 16 controls, who underwent a stress CMR study to rule out obstructive coronary artery disease. All patients were examined on a 1.5-T system and the study protocol comprised both, first-pass myocardial perfusion imaging (MPI) and velocity-encoded (VENC) phase-contrast imaging of CSF during rest and adenosine stress.
RESULTS: 1P-MPR was significantly decreased only in HCM patients compared to controls (1.14 vs. 1.43, p = 0.045) whereas CSF-MPR was significantly reduced in both patient groups, HCM and DCM, compared to controls (2.38 and 2.07 vs. 3.18, p = 0.041 and p = 0.032). CSF-MBF at maximal stress was significantly lower in HCM and DCM patients compared to the control group (0.11 and 1.23 vs. 1.58 ml/min/g, p = 0.008 and p = 0.040). A moderate but significant correlation between CSF-MPR and 1P-MPR was observed (r = 0.39, p = 0.011). A negative correlation between LV wall thickness and CSF-MBF at rest and stress was found in the DCM group using VENC-based CSF measurements (r = - 0.64, p = 0.013 and r = - 0.69, p = 0.006)-but not using 1P-MPI. Post-proceeding analysis regarding 1P-MPR and CSF-MPR measurements required 20.1 and 6.5 min, respectively (p < 0.001).
CONCLUSION: The presence of microvascular disease can be non-invasively and quickly detected by VENC-based CSF-MPR measurements during routine stress perfusion CMR in both HCM and DCM patients. Compared to conventional 1P-MPI, VENC-based CSF-MPR is particularly useful in DCM patients with thinned ventricular walls.

Entities:  

Keywords:  CMR; Coronary sinus flow; DCM; HCM; Myocardial perfusion

Mesh:

Year:  2018        PMID: 29774406     DOI: 10.1007/s00392-018-1279-2

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  34 in total

Review 1.  MR myocardial perfusion imaging.

Authors:  Otavio R Coelho-Filho; Carsten Rickers; Raymond Y Kwong; Michael Jerosch-Herold
Journal:  Radiology       Date:  2013-03       Impact factor: 11.105

Review 2.  Current perspectives in coronary microvascular dysfunction.

Authors:  Joy S Shome; Divaka Perera; Sven Plein; Amedeo Chiribiri
Journal:  Microcirculation       Date:  2017-01       Impact factor: 2.628

Review 3.  Cardiac PET perfusion tracers: current status and future directions.

Authors:  Jamshid Maddahi; René R S Packard
Journal:  Semin Nucl Med       Date:  2014-09       Impact factor: 4.446

Review 4.  Quantitative Assessment of Coronary Microvascular Function: Dynamic Single-Photon Emission Computed Tomography, Positron Emission Tomography, Ultrasound, Computed Tomography, and Magnetic Resonance Imaging.

Authors:  Attila Feher; Albert J Sinusas
Journal:  Circ Cardiovasc Imaging       Date:  2017-08       Impact factor: 7.792

5.  Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging.

Authors:  Jonathan R Panting; Peter D Gatehouse; Guang-Zhong Yang; Frank Grothues; David N Firmin; Peter Collins; Dudley J Pennell
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

6.  Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.

Authors:  Franco Cecchi; Iacopo Olivotto; Roberto Gistri; Roberto Lorenzoni; Giampaolo Chiriatti; Paolo G Camici
Journal:  N Engl J Med       Date:  2003-09-11       Impact factor: 91.245

7.  Diagnostic value of global myocardial perfusion reserve assessment based on coronary sinus flow measurements using cardiovascular magnetic resonance in addition to myocardial stress perfusion imaging.

Authors:  Zornitsa Shomanova; Anca Florian; Michael Bietenbeck; Johannes Waltenberger; Udo Sechtem; Ali Yilmaz
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2017-05-01       Impact factor: 6.875

Review 8.  The non-invasive documentation of coronary microcirculation impairment: role of transthoracic echocardiography.

Authors:  Pawel Petkow Dimitrow; Maurizio Galderisi; Fausto Rigo
Journal:  Cardiovasc Ultrasound       Date:  2005-08-04       Impact factor: 2.062

9.  Impairment of Coronary Flow Reserve Evaluated by Phase Contrast Cine-Magnetic Resonance Imaging in Patients With Heart Failure With Preserved Ejection Fraction.

Authors:  Shingo Kato; Naka Saito; Hidekuni Kirigaya; Daiki Gyotoku; Naoki Iinuma; Yuka Kusakawa; Kohei Iguchi; Tatsuya Nakachi; Kazuki Fukui; Masaaki Futaki; Tae Iwasawa; Kazuo Kimura; Satoshi Umemura
Journal:  J Am Heart Assoc       Date:  2016-02-23       Impact factor: 5.501

10.  Myocardial perfusion cardiovascular magnetic resonance: optimized dual sequence and reconstruction for quantification.

Authors:  Peter Kellman; Michael S Hansen; Sonia Nielles-Vallespin; Jannike Nickander; Raquel Themudo; Martin Ugander; Hui Xue
Journal:  J Cardiovasc Magn Reson       Date:  2017-04-07       Impact factor: 5.364

View more
  5 in total

1.  FIFA World Cup 2018: effect of emotional stress on conventional heart rate variability metrics.

Authors:  Wolfgang Hamm; Viktoria Bogner-Flatz; Axel Bauer; Stefan Brunner
Journal:  Clin Res Cardiol       Date:  2019-08-06       Impact factor: 5.460

2.  "Myocardial transit-time" (MyoTT): a novel and easy-to-perform CMR parameter to assess microvascular disease.

Authors:  Grigorios Chatzantonis; Michael Bietenbeck; Anca Florian; Claudia Meier; Dennis Korthals; Holger Reinecke; Ali Yilmaz
Journal:  Clin Res Cardiol       Date:  2019-07-18       Impact factor: 5.460

3.  Nucleotide ecto-enzyme metabolic pattern and spatial distribution in calcific aortic valve disease; its relation to pathological changes and clinical presentation.

Authors:  Barbara Kutryb-Zajac; Patrycja Jablonska; Marcin Serocki; Alicja Bulinska; Paulina Mierzejewska; Daniela Friebe; Christina Alter; Agnieszka Jasztal; Romuald Lango; Jan Rogowski; Rafal Bartoszewski; Ewa M Slominska; Stefan Chlopicki; Jürgen Schrader; Magdi H Yacoub; Ryszard T Smolenski
Journal:  Clin Res Cardiol       Date:  2019-05-29       Impact factor: 5.460

4.  Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy.

Authors:  Grigorios Chatzantonis; Michael Bietenbeck; Anca Florian; Claudia Meier; Philipp Stalling; Dennis Korthals; Holger Reinecke; Ali Yilmaz
Journal:  Clin Res Cardiol       Date:  2020-05-05       Impact factor: 5.460

5.  A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients.

Authors:  Stefanos Drakos; Grigorios Chatzantonis; Michael Bietenbeck; Georg Evers; Arik Bernard Schulze; Michael Mohr; Helena Fonfara; Claudia Meier; Ali Yilmaz
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.